AOD 9604: Chemical Identity AOD 9604 is a synthetic growth hormonederived peptide fragment corresponding to the C-terminal lipolytic region of human GH, with an additional N-terminal tyrosine residue incorporated to improve structural stability in laboratory systems
Early research is mostly from animal models, so the clinical picture is still forming
Research Context In experimental settings, FOXO4-DRI is used to explore: Cellular senescence and ageing-associated signalling cascades FOXO4p53 interaction dynamics in senescent cell survival Experimental senescence-focused research models Stress and cytotoxic response pathways involving senescence markers Comparative in-vitro studies alongside FOXO4 and related research compounds Its structured D-retro-inverso design makes FOXO4-DRI suitable for controlled laboratory research where precise modulation of FOXO4-linked pathways is required
Antioxidants (AREDS2 formula with vitamins C, E, zinc, lutein) slow progression modestly
Who Is an Ideal Candidate for DSIP
Immune System Boost: Strengthen your bodys natural defenses
